Andre st. Amant

Andre St. Amant is an accomplished scientist with extensive experience in organic chemistry and drug development. Currently serving as a Senior Scientist II at Exelixis since September 2021, Andre designs and synthesizes molecules, manages CRO collaborations, and leads chemistry projects. Previous positions include a Postdoctoral Research Fellow at Genentech, where Andre developed new antibody-drug technology, and a Postdoctoral Scholar at Stanford University, where the first selective CDK19 kinase inhibitor was developed. Andre earned a PhD in Organic Chemistry from UC Santa Barbara and holds a Master's and Bachelor's degree in Organic Chemistry and Chemistry/Biochemistry from Western University. Early career experiences include laboratory technician roles and food service positions, demonstrating a well-rounded professional background.